Menopausal Status and Estrogen Receptor Genotypes Influenced the Severity of Hot Flashes After Tamoxifen Treatment

Clinical Pharmacology and Therapeutics - United States
doi 10.1016/j.clpt.2004.11.017
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Continuous Transdermal Nitroglycerin Therapy for Menopausal Hot Flashes

Menopause
GynecologyObstetrics
2016English

Risk Factors, Pathophysiology, and Treatment of Hot Flashes in Cancer

CA - A Cancer Journal for Clinicians
OncologyHematology
2013English

New Pathways in the Treatment for Menopausal Hot Flushes

The Lancet
Medicine
2017English

Estrogen Receptor Regulates E2F1 Expression to Mediate Tamoxifen Resistance

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2010English

An Exploratory Study on Perceived Relationship of Alcohol, Caffeine, and Physical Activity on Hot Flashes in Menopausal Women

Health
2010English

CYP2D6 Genotyping and Tamoxifen in the Treatment of Post-Menopausal Breast Cancer - A Reply

British Journal of Clinical Pharmacology
Pharmacology
2014English

An Estrogen Receptor-Selective Coactivator: A Potential Regulator of Tamoxifen Effectiveness in Breast Cancer Treatment and Prevention

2002English

The Tamoxifen-Responsive Estrogen Receptor Α Mutant D351Y Shows Reduced Tamoxifen-Dependent Interaction With Corepressor Complexes

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

NCCTG N10C2 (Alliance): A Double-Blind, Placebo-Controlled Study of Magnesium Supplements to Reduce Menopausal Hot Flashes.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy